ICAN Nutrition Education and Research
Seoul, 07327, South Korea
NCT Number: NCT03267901
Investigators planed to conduct a randomized, controlled, crossover trial to examine the effects of daily walnuts intake among Korean subjects with metabolic syndrome. Primary objective of this study was to investigate the effects of daily walnut intake on changes of metabolic syndrome indices in Koreans with metabolic syndrome age over 30 years old. This study was consisted of four periods: run-in, first intervention, wash-out, and second intervention phases. As 16 weeks of first intervention period began after the run-in phase, the subjects were randomly assigned into one of two groups: walnut group and control group. Participants in walnut group consumed 45 grams of walnuts on a daily basis and participants in control group were provided iso-caloric white bread for first 16 weeks. After the first intervention and wash-out period (6 weeks), second intervention which is crossover of first intervention was started during the next 16 weeks. Anthropometric measurements and biochemical analyses were done at the beginning and the end of each intervention (0, 16, 22, and 38 weeks of trial). Habitual diet was randomly observed using 3-day diet record once during each phase.
Investigators expected to evaluate 1)effects of walnut ingestion on reverting metabolic syndrome to normal status especially by reducing waist circumference and improving serum levels of triglyceride and high-density lipoprotein, 2)beneficial effects of daily walnut consumption on changes of body composition in the subjects with metabolic syndrome, and 3)regulatory effects of daily walnut intake on inflammatory markers and diabetic markers.
Looking for future studies?
Notify Me30 year–55 year
All sexes
Interventional
Not applicable
Seoul, 07327, South Korea
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
at least three out of five metabolic syndrome components
Exclusion criteria
45 g of walnut / iso-caloric white bread
Time frame: after 16 weeks of daily walnut consumption
Waist circumferences (cm) were obtained at the midpoint between the lowest rib and the iliac crest and rounded to the nearest 0.1 cm after inhalation and exhalation.
Time frame: after 16 weeks of daily walnut consumption
Serum triglycerides (mg/dL) levels were measured by an enzymatic-colorimetric method.
Time frame: after 16 weeks of daily walnut consumption
High density lipoprotein cholesterol (mg/dL) levels were determined by a homogeneous enzymatic-colorimetric method.
Time frame: after 16 weeks of daily walnut consumption
Blood pressure (mmHg) was measured on the right arm using an up-load blood pressure monitor with participants in a comfortably seated position after at least a 5-minute rest.
Time frame: after 16 weeks of daily walnut consumption
Blood glucose levels (mg/dL) were measured using blood glucose monitor and test stripts from the finger tip.
Time frame: after 16 weeks of daily walnut consumption
Serum total cholesterol levels (ml/dL) were measured by an enzymatic-colorimetric method.
Time frame: after 16 weeks of daily walnut consumption
Serum apolipoprotein B (ml/dL) was measured using a turbidimetric immunoassay.
Time frame: after 16 weeks of daily walnut consumption
Blood adiponectin (ug/mL) levels were measured using ELISA.
Time frame: after 16 weeks of daily walnut consumption
Blood leptin (ug/mL) levels were measured using ELISA.
Time frame: after 16 weeks of daily walnut consumption
Serum insulin (μU/mL) was measured with a commercially available kit, the ultrasensitive insulin ELISA kit using an Epoch microplate spectrophotometer.
Time frame: after 16 weeks of daily walnut consumption
Low-density lipoprotein cholesterol levels (ml/dL) were determined by a homogeneous enzymatic-colorimetric method.
ICAN Nutrition Education and Research
Industry
Effects of Daily Walnut Intake Among the Subjects With Metabolic Syndrome in South Korea
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05956886
Dyssomnias, Glucose Metabolism Disorders
Newark, Delaware, United States
View Trial DetailsNCT07739602
Glucose Metabolism Disorders, Hyperinsulinism
Wroclaw, Poland
View Trial DetailsNCT04057339
Behavior, Fasting
La Jolla, California, United States
View Trial DetailsNCT07702669
Glucose Metabolism Disorders, Hyperinsulinism
Harbin, Heilongjiang, China
View Trial Details